Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Verapamil prodrug enhances activity of cytotoxic agents in resistant cell lines

June 26, 1998

Interim report on phase I testing of bizelesin, a bifunctional alkylating agent

June 26, 1998

Genta to commence phase I/IIa trial with G-3139

June 26, 1998

Megabios seeks partners for oncology programs

June 26, 1998

Pharmacokinetics and metabolism of TAT-59 investigated in animals

June 25, 1998

Broadened use of Taxotere in breast cancer cleared by FDA

June 25, 1998

Flavone acetic acid analogue suppresses tumor blood perfusion, patient study shows

June 25, 1998

First patients being treated with bombesin/GRP antagonist RC-3095

June 25, 1998

Cationic peptides exert selective antitumor activity against sensitive and resistant cell lines

June 25, 1998

Anthracenedione analogue BBR-2778 moves to phase I testing

June 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...